ResultsIQ › Latest results › Fermenta Biotech Limited
Fermenta Biotech Limited Q2 FY27 results press release summary
NSE: FERMENTA · BSE: 506414
Results press release of 5 Nov 2026, summarised by AI from the filing.
Fermenta H1FY27 consolidated revenue ₹261.9 cr, down 7% YoY, with EBITDA down 34% on lower animal nutrition and prior-year one-offs.
Key takeaways
- H1 revenue Consolidated revenue ₹261.9 cr, down 7% YoY; EBITDA ₹45.6 cr, down 34% YoY; PAT ₹18.9 cr, down 52% YoY.
- Capacity timeline VITADEE Green® capacities should be available from Q2FY28; Calcifediol expected ready for regulatory approvals by end of FY27.
- India share India rose to 51% of consolidated revenue in H1FY27 from 40% a year earlier.
- Human Nutrition Human Nutrition revenue grew 2% despite volumes down 13% YoY, and is now close to two-thirds of revenue.
- Animal Nutrition Animal nutrition volumes down 31% and average realisation down 35% YoY; sales volumes not pursued at low prices.
Fermenta Biotech Limited Q2 FY27 results
As filed: Revenue ₹117 cr, EBITDA ₹24.1 cr, PAT ₹14.0 cr, EBITDA margin 20.6%.
Not scored. No result for the same quarter last year.
Earlier results and the share price after them
- Q1 FY27: Revenue ₹112 cr, EBITDA ₹23.0 cr, PAT ₹15.0 cr, EBITDA margin 20.6%. Not scored. No result for the same quarter last year. Share price after the results: −11.7% in 30 days (Nifty 500: −3.3%).
Past price moves after results do not indicate future moves. Not a recommendation.
Fermenta Biotech Limited earnings call, investor presentation and press release summaries
- Q2 FY27: Results deck (6 Nov 2026), Results press release (5 Nov 2026)
- Q1 FY27: Results deck (11 Aug 2026), Results press release (11 Aug 2026)
- Q4 FY26: Results deck (26 May 2026), Results press release (26 May 2026)
- Q3 FY26: Results deck (11 Feb 2026), Results press release (9 Feb 2026)
- Q2 FY26: Results deck (12 Nov 2025), Results press release (11 Nov 2025)
- Q1 FY26: Results deck (13 Aug 2025)
- Q4 FY25: Results deck (4 Jun 2025), Results press release (28 May 2025)
Figures from the company's filings with NSE and BSE. Not investment advice.